As of January 8 at 3:26:12 PM EST. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 136.9k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
BYRNES MICHAEL Chief Financial Officer | Stock Award(Grant) at price 1.68 per share. | Direct | 2,334 | May 15, 2024 |
WORLAND STEPHEN T Chief Executive Officer | Stock Award(Grant) at price 1.68 per share. | Direct | 3,039 | May 15, 2024 |
SR ONE CAPITAL MANAGEMENT, LLC Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.61 per share. | Indirect | 369,457 | Nov 27, 2023 |
BYRNES MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.50 per share. | Direct | 2,250 | Nov 15, 2023 |
WORLAND STEPHEN T Chief Executive Officer | Stock Award(Grant) at price 0.50 per share. | Direct | 2,973 | Nov 15, 2023 |
WORLAND STEPHEN T Chief Executive Officer | Conversion of Exercise of derivative security at price 0.52 per share. | Direct | 17,575 | Aug 11, 2023 |
BYRNES MICHAEL Chief Financial Officer | Stock Award(Grant) at price 0.68 per share. | Direct | 3,331 | May 15, 2023 |
WORLAND STEPHEN T Chief Executive Officer | Stock Award(Grant) at price 0.68 per share. | Direct | 4,384 | May 15, 2023 |
Related Tickers
RNXT RenovoRx, Inc.
1.3188
-0.09%
INDP Indaptus Therapeutics, Inc.
0.9700
0.00%
VRPX Virpax Pharmaceuticals, Inc.
0.3768
+3.06%
TFFP TFF Pharmaceuticals, Inc.
0.0650
-60.05%
BTTX Better Therapeutics, Inc.
0.0001
0.00%
PXMD PaxMedica, Inc.
0.0650
-1.22%
TVGNW Tevogen Bio Holdings Inc.
0.0750
-5.66%
ZVSA ZyVersa Therapeutics, Inc.
1.5200
+28.81%
PSTV Plus Therapeutics, Inc.
1.2200
+1.67%
ADIL Adial Pharmaceuticals, Inc.
1.0100
-1.94%